ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119076	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/27/2026 at 18:00, 1 month 24 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
ABIVAX communique le nombre d'actions composant son capital social et le nombre total de droits de vote conformément aux réglementations en vigueur. Pour plus d'informations, visitez www.abivax.com

Droits De Vote Capital Social Biotechnologie Abivax Réglementation
BRIEF

published on 04/22/2026 at 22:10, 1 month 29 days ago

Abivax dévoile des données clés sur l'obefazimod à la Digestive Disease Week

Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques Digestive Disease Week
BRIEF

published on 04/22/2026 at 22:10, 1 month 29 days ago

Abivax unveils key data on obefazimod at Digestive Disease Week

Abivax Obefazimod Ulcerative Colitis Clinical Trials Digestive Disease Week
BRIEF

published on 04/22/2026 at 22:10, 1 month 29 days ago

Abivax présentera des données sur l'obéfazimod lors de la Digestive Disease Week®

Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques De Phase 3 DDW 2026
BRIEF

published on 04/22/2026 at 22:10, 1 month 29 days ago

Abivax to Present Data on Obefazimod at Digestive Disease Week®

Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
PRESS RELEASE

published on 04/22/2026 at 22:05, 1 month 29 days ago

Abivax présentera des données sur l’obefazimod lors de la Digestive Disease Week
Abivax présentera des données sur l’obefazimod lors de la Digestive Disease Week 2026 à Chicago, mettant en avant l’efficacité, la tolérance et les résultats rapportés par les patients, ainsi que les activités antifibrotiques précliniques

Abivax Obefazimod Maladies Inflammatoires Chroniques Rectocolite Hémorragique Digestive Disease Week
PRESS RELEASE

published on 04/22/2026 at 22:05, 1 month 29 days ago

Abivax présentera des données sur l’obefazimod lors de la Digestive Disease Week
Abivax présentera des données sur l’obefazimod lors de la Digestive Disease Week, mettant en avant l’efficacité et la tolérance du médicament dans le traitement de maladies inflammatoires chroniques de l’intestin

Abivax Obefazimod Rectocolite Hémorragique Maladies Inflammatoires Digestive Disease Week
PRESS RELEASE

published on 04/22/2026 at 22:05, 1 month 29 days ago

Abivax to Present Data on Obefazimod at Digestive Disease Week®
Abivax to present data on Obefazimod at Digestive Disease Week, showcasing efficacy, safety, and patient outcomes from Phase 3 ABTECT program and preclinical anti-fibrotic models

Abivax Obefazimod Clinical Trials Digestive Disease Week Inflammatory Bowel Disease
BRIEF

published on 04/20/2026 at 22:10, 2 months 1 day ago

Abivax: Annual General Meeting scheduled for May 11, 2026

Biotechnology Abivax Obefazimod General Assembly Preparatory Documents
BRIEF

published on 04/20/2026 at 22:10, 2 months 1 day ago

Abivax : Assemblée Générale Annuelle prévue le 11 mai 2026

Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires

Accesswire

Published on 06/20/2026 at 01:00, 1 day 23 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 19 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 23 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 23 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 1 day 2 hours ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 18 hours ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 4 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 4 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 2 days 5 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 2 days 4 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 4 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 4 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 4 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 2 days 5 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE